Improving outcomes in diabetic nephropathy.
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2010
At a glance
- Drugs Losartan (Primary) ; Spironolactone (Primary) ; Lisinopril
- Indications Diabetic nephropathies; Hypertension; Proteinuria
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2009 Primary endpoint 'Urinary albumin:creatinine ratio' has been met.
- 01 Dec 2009 Results published in the Journal of the American Society of Nephrology.